Dermatol. praxi. 2025;19(2):72-74 | DOI: 10.36290/der.2025.008

The psychological impact of Hidradenitis Suppurativa: How the disease affects patients' quality of life

MUDr. Júlia Bartková, MBA, MPH1, 2, Marie Tormová2, MUDr. Gabriela Bakšová3
1 Klinika popálenin a plastické chirurgie, Fakultní nemocnice Brno
2 Lékařská fakulta Masarykovy univerzity, Brno
3 Dermatologická ambulace, Nemocnice Poprad, a. s., Slovenská republika

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that significantly affects patients' quality of life, not only physically but also psychologically. This condition, which affects areas with a high concentration of apocrine glands, is characterized by painful abscesses and sinus tracts. Studies show that patients with HS face an increased risk of psychological issues, particularly depression and anxiety, which can worsen overall well-being and hinder daily functioning. This article focuses on the psychological impact of HS in adult patients, including its effects on their social relationships and overall quality of life. Early diagnosis and psychological support are essential for improving patients' health and mental well-being.

Keywords: hidradenitis suppurativa, chronic skin disease, psychological impact, depression, anxiety.

Accepted: May 12, 2025; Published: May 30, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartková J, Tormová M, Bakšová G. The psychological impact of Hidradenitis Suppurativa: How the disease affects patients' quality of life. Dermatol. praxi. 2025;19(2):72-74. doi: 10.36290/der.2025.008.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 30.5.2026

    References

    1. Hercogová J, et al. Klinická dermatovenerologie 1. díl. Praha: Mladá fronta, a.s.; 2019.
    2. Moltrasio C, Tricarico PM, Romagnuolo M, et al. Hidradenitis Suppurativa: A Perspective on Genetic Factors Involved in the Disease. Biomedicines. 2022;10(8):2039. doi: 10.3390/biomedicines10082039 Go to original source... Go to PubMed...
    3. Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59(4):596-601. doi: 10.1016/j.jaad.2008. 06. 020 Go to original source...
    4. Posso-De Los Rios CJ, Sarfo A, Ghias M, et al. Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018. Exp Dermatol. 2019;28(7):769-775. doi: 10.1111/exd.13928. Go to original source... Go to PubMed...
    5. Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59(4):596-601. doi: 10.1016/j.jaad.2008. 06. 020. Go to original source...
    6. Kirsten N, Petersen J, Hagenström K, et al. Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach. J Eur Acad Dermatol Venereol. 2020;34(1):174-179. doi: 10.1111/jdv.15940. Go to original source... Go to PubMed...
    7. Vinding GR, Miller IM, Zarchi K, et al. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol. 2014;170(4):884-889. doi: 10.1111/bjd.12787. Go to original source... Go to PubMed...
    8. Ingram JR, Jenkins-Jones S, Knipe DW, et al. Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol. 2018;178(4):917-924. doi: 10.1111/bjd.16101. Go to original source... Go to PubMed...
    9. Garg A, Kirby JS, Lavian J, et al. Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States. JAMA Dermatol. 2017;153(8):760-764. doi: 10.1001/jamadermatol.2017.0201. Go to original source... Go to PubMed...
    10. Lee JH, Kwon HS, Jung HM,et al. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2018;32(10):1784-1790. doi: 10.1111/jdv.15071. Go to original source... Go to PubMed...
    11. Hayama K, Fujita H, Hashimoto T,et al. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries. J Dermatol. 2020;47(7):743-748. doi: 10.1111/1346-8138.15378. Go to original source... Go to PubMed...
    12. Ballard K, Shuman VL. Hidradenitis Suppurativa. [Updated 2024 May 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534867/.
    13. Aparício Martins I, Figueira Vilela B, Cabete J. Diagnostic Delay in Hidradenitis Suppurativa: Still an Unsolved Problem. Skin Appendage Disord. 2024;10(2):129-132. doi: 10.1159/000534845. Go to original source... Go to PubMed...
    14. Kokolakis G, Wolk K, Schneider-Burrus S, et al. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System. Dermatology. 2020;236(5):421-430. doi: 10.1159/000508787. Go to original source... Go to PubMed...
    15. Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020;82(5):1045-1058. doi: 10.1016/j.jaad.2019. 08. 090. Go to original source...
    16. von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144(4):809-813. doi: 10.1046/j.1365-2133.2001.04137.x. Go to original source... Go to PubMed...
    17. Tzur Bitan D, Berzin D, Cohen A. Hidradenitis Suppurativa and Bipolar Disorders: A Population-Based Study. Dermatology. 2020;236(4):298-304. doi: 10.1159/000504535. Go to original source... Go to PubMed...
    18. Caccavale S, Tancredi V, Boccellino MP, et al. Hidradenitis Suppurativa Burdens on Mental Health: A Literature Review of Associated Psychiatric Disorders and Their Pathogenesis. Life (Basel). 2023;13(1):189. doi: 10.3390/life13010189. Go to original source... Go to PubMed...
    19. Rymaszewska JE, Krajewski PK, Szczęch J, et al. Depression and anxiety in hidradenitis suppurativa patients: a cross-sectional study among Polish patients. Postepy Dermatol Alergol. 2023;40(1):35-39. doi: 10.5114/ada.2022.119080. Go to original source... Go to PubMed...
    20. Patel KR, Lee HH, Rastogi S, et al. Association between hidradenitis suppurativa, depression, anxiety, and suicidality: A systematic review and meta-analysis. J. Am. Acad. Dermatol. 2020;83:737-744. doi: 10.1016/j.jaad.2019. 11. 068. Go to original source...
    21. Sampogna F, Fania L, Mastroeni S, et al. Correlation between Depression, Quality of Life and Clinical Severity in Patients with Hidradenitis Suppurativa. Acta Derm Venereol. 2020;100(18):adv00319. Published 2020 Nov 12. doi: 10.2340/00015555-3647. Go to original source... Go to PubMed...
    22. Singh R, Kelly KA, Senthilnathan A, et al. Stigmatization, a social perception which may have a debilitating impact on hidradenitis suppurativa patients: an observational study. Arch Dermatol Res. 2023;315(4):1049-1052. doi: 10.1007/s00403-022-02412-5. Go to original source... Go to PubMed...
    23. Koumaki D, Efthymiou O, Bozi E. Perspectives on perceived stigma and self-stigma in patients with hidradenitis suppurativa. Clin Cosmet Investig Dermatol. 2019;16(12):785-790. https://doi.org/10.2147/CCID.S180036. Go to original source... Go to PubMed...
    24. Phan K, Huo YR, Smith SD. Hidradenitis suppurativa and psychiatric comorbidities, suicides and substance abuse: Systematic review and meta-analysis. Ann. Transl. Med. 2020;8:821. doi: 10.21037/atm-20-1028. Go to original source... Go to PubMed...
    25. Ortiz-Álvarez J, Hernández-Rodríguez JC, Durán-Romero AJ, et al. Hidradenitis suppurativa and suicide risk: A multivariate analysis in a disease with a high psychological burden. Arch. Dermatol. Res. 2022:1-6. doi: 10.1007/s00403-022-02391-7. Go to original source... Go to PubMed...
    26. Tzur Bitan D, Berzin D, Cohen AD. Hidradenitis suppurativa and schizophrenia: A nationwide cohort study. J. Eur. Acad. Dermatol. Venereol. 2020;34:574-579. doi: 10.1111/jdv.15997. Go to original source... Go to PubMed...
    27. Garg A, Papagermanos V, Midura M, et al. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States. J. Am. Acad. Dermatol. 2018;79:495-500. doi: 10.1016/j.jaad.2018. 02. 053. Go to original source...
    28. Theut Riis P, Pedersen OB, Sigsgaard V, et al. Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: A cross-sectional study. Br. J. Dermatol. 2019;180:774-781. doi: 10.1111/bjd.16998. Go to original source... Go to PubMed...
    29. Ford J, Thomas F, Byng R, et al. Asking about self-harm and suicide in primary care: Moral and practical dimensions. Patient Educ. Couns. 2021;104:826-835. doi: 10.1016/j.pec.2020. 09. 037. Go to original source...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.